CN1538968A - 新型化合物 - Google Patents

新型化合物 Download PDF

Info

Publication number
CN1538968A
CN1538968A CNA028152514A CN02815251A CN1538968A CN 1538968 A CN1538968 A CN 1538968A CN A028152514 A CNA028152514 A CN A028152514A CN 02815251 A CN02815251 A CN 02815251A CN 1538968 A CN1538968 A CN 1538968A
Authority
CN
China
Prior art keywords
formula
compound
group
represent
amino
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CNA028152514A
Other languages
English (en)
Chinese (zh)
Inventor
ά
戴维·格里菲思
����� Լ�������
克雷格·约翰斯顿
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1538968A publication Critical patent/CN1538968A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Use Of Switch Circuits For Exchanges And Methods Of Control Of Multiplex Exchanges (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
CNA028152514A 2001-07-25 2002-07-19 新型化合物 Pending CN1538968A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0102617A SE0102617D0 (sv) 2001-07-25 2001-07-25 Novel compounds
SE01026178 2001-07-25

Publications (1)

Publication Number Publication Date
CN1538968A true CN1538968A (zh) 2004-10-20

Family

ID=20284945

Family Applications (1)

Application Number Title Priority Date Filing Date
CNA028152514A Pending CN1538968A (zh) 2001-07-25 2002-07-19 新型化合物

Country Status (17)

Country Link
US (1) US7098240B2 (cg-RX-API-DMAC7.html)
EP (1) EP1421079B1 (cg-RX-API-DMAC7.html)
JP (2) JP2004536869A (cg-RX-API-DMAC7.html)
KR (1) KR20040018521A (cg-RX-API-DMAC7.html)
CN (1) CN1538968A (cg-RX-API-DMAC7.html)
AT (1) ATE353327T1 (cg-RX-API-DMAC7.html)
BR (1) BR0211472A (cg-RX-API-DMAC7.html)
CA (1) CA2454702A1 (cg-RX-API-DMAC7.html)
DE (1) DE60218048T2 (cg-RX-API-DMAC7.html)
ES (1) ES2280559T3 (cg-RX-API-DMAC7.html)
IL (1) IL160023A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA04000755A (cg-RX-API-DMAC7.html)
NO (1) NO20040314L (cg-RX-API-DMAC7.html)
NZ (1) NZ530751A (cg-RX-API-DMAC7.html)
SE (1) SE0102617D0 (cg-RX-API-DMAC7.html)
WO (1) WO2003010163A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA200400494B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107739370A (zh) * 2017-10-26 2018-02-27 中国药科大学 吡咯酮类brd4蛋白抑制剂的制备方法以及用途

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0003154D0 (en) * 2000-02-12 2000-04-05 Astrazeneca Uk Ltd Novel compounds
JP4544857B2 (ja) * 2001-06-11 2010-09-15 ヴァイロケム ファーマ インコーポレイテッド Ｆｌａｖｉｖｉｒｕｓ感染の治療または予防のための化合物および方法
SE0102616D0 (sv) 2001-07-25 2001-07-25 Astrazeneca Ab Novel compounds
ATE414697T1 (de) * 2001-10-04 2008-12-15 Smithkline Beecham Corp Nf-kb-inhibitoren
AU2003249683A1 (en) * 2002-06-06 2003-12-22 Smithkline Beecham Corporation Nf-:b inhibitors
PT1569929E (pt) 2002-12-10 2010-06-18 Virochem Pharma Inc Compostos e métodos para o tratamento ou prevenção de infecções por flavivírus
SE0300092D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
SE0300091D0 (sv) 2003-01-15 2003-01-15 Astrazeneca Ab Novel compounds
US7790724B2 (en) 2003-04-25 2010-09-07 Janssen Pharmaceutica N.V. c-fms kinase inhibitors
WO2004096795A2 (en) * 2003-04-25 2004-11-11 3-Dimensional Pharmaceuticals, Inc. C-fms kinase inhibitors
US20050113566A1 (en) * 2003-04-25 2005-05-26 Player Mark R. Inhibitors of C-FMS kinase
US7427683B2 (en) * 2003-04-25 2008-09-23 Ortho-Mcneil Pharmaceutical, Inc. c-fms kinase inhibitors
EP1493739A1 (fr) * 2003-07-03 2005-01-05 Warner-Lambert Company LLC Dérivés thiophényliques d'aminoacides, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
US20050085531A1 (en) * 2003-10-03 2005-04-21 Hodge Carl N. Thiophene-based compounds exhibiting ATP-utilizing enzyme inhibitory activity, and compositions, and uses thereof
EP2305671A1 (en) * 2004-01-05 2011-04-06 AstraZeneca AB Thiophene and thiazole derivatives as CHK1 inhibitors
PE20060373A1 (es) 2004-06-24 2006-04-29 Smithkline Beecham Corp Derivados 3-piperidinil-7-carboxamida-indazol como inhibidores de la actividad cinasa de ikk2
TW200626142A (en) 2004-09-21 2006-08-01 Glaxo Group Ltd Chemical compounds
EP2546246A3 (en) * 2005-05-13 2013-04-24 Virochem Pharma Inc. Compounds and methods for the treatment or prevention of flavivirus infections
US8063071B2 (en) 2007-10-31 2011-11-22 GlaxoSmithKline, LLC Chemical compounds
TWI380973B (zh) 2005-06-30 2013-01-01 Smithkline Beecham Corp 化合物
AU2007321677B2 (en) 2006-11-15 2013-04-11 Vertex Pharmaceuticals (Canada) Incorporated Thiophene analogues for the treatment or prevention of flavivirus infections
KR20090109551A (ko) * 2007-01-15 2009-10-20 산텐 세이야꾸 가부시키가이샤 ＩκＢ 키나아제 β 저해 활성을 갖는 신규 인돌 유도체
AR065804A1 (es) 2007-03-23 2009-07-01 Smithkline Beecham Corp Compuesto de indol carboxamida, composicion farmaceutica que lo comprende y uso de dicho compuesto para preparar un medicamento
KR20160029870A (ko) 2008-04-21 2016-03-15 오토노미, 인코포레이티드 귀 질환 및 병태를 치료하기 위한 귀 조제물
US11969501B2 (en) 2008-04-21 2024-04-30 Dompé Farmaceutici S.P.A. Auris formulations for treating otic diseases and conditions
WO2010007972A1 (ja) * 2008-07-14 2010-01-21 参天製薬株式会社 カルバモイル基、ウレイド基及び置換オキシ基を有する新規インドール誘導体
CN102131774A (zh) * 2008-08-25 2011-07-20 参天制药株式会社 含有脲基、氨基羰基及可以具有取代基的二环式基团作为取代基的新型吡咯衍生物
WO2010102968A1 (en) 2009-03-10 2010-09-16 Glaxo Group Limited Indole derivatives as ikk2 inhibitors
GB0913345D0 (en) 2009-07-31 2009-09-16 Astrazeneca Ab New combination 802
WO2011061527A1 (en) 2009-11-17 2011-05-26 Astrazeneca Ab Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases
GB201016912D0 (en) 2010-10-07 2010-11-24 Astrazeneca Ab Novel combination
GB201021979D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab New compound
GB201021992D0 (en) 2010-12-23 2011-02-02 Astrazeneca Ab Compound
EP2520292A1 (en) 2011-05-06 2012-11-07 Helmholtz-Zentrum für Infektionsforschung GmbH Use of spirangiens for the treatment or prevention of IL-8 or IL-6 mediated disorders
CN109689027A (zh) 2016-06-29 2019-04-26 奥德纳米有限公司 甘油三酯耳用制剂及其用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1468012A (en) 1973-08-09 1977-03-23 Beecham Group Ltd 2-amino-3-carboxy-thiophene derivatives
DE3529247A1 (de) 1985-05-17 1986-11-20 Bayer Ag, 5090 Leverkusen Verwendung von thienylharnstoffen und -isoharnstoffen als leistungsfoerdernde mittel bei tieren, neue thienylharnstoffe und -isoharnstoffe und ihre herstellung
EP0912548A1 (en) 1996-07-11 1999-05-06 Pfizer Inc. Pyridylpyrrole compounds useful as interleukin- and tnf antagonists
PT853083E (pt) * 1997-01-06 2001-12-28 Pfizer Composto de piridilfurano e piridiltiofeno e sua utilizacao farmaceutica
US6809088B2 (en) * 1997-03-24 2004-10-26 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
US6037340A (en) 1997-05-28 2000-03-14 Cadus Pharmaceutical Corporation Synthesis and use of thiophene- and pyrrole-based heteroaromatic compounds
DE19744026A1 (de) 1997-10-06 1999-04-08 Hoechst Marion Roussel De Gmbh Pyrazol-Derivate, ihre Herstellung und ihre Verwendung in Arzneimitteln
WO1999046244A1 (en) 1998-03-12 1999-09-16 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (ptpases)
HN2000000051A (es) 1999-05-19 2001-02-02 Pfizer Prod Inc Derivados heterociclicos utiles como agentes anticancerosos
NZ521068A (en) * 2000-03-29 2005-04-29 Cyclacel Ltd 2-substituted 4-heteroaryl-pyrimidines and their use in the treatment of proliferative disorders
US6414013B1 (en) 2000-06-19 2002-07-02 Pharmacia & Upjohn S.P.A. Thiophene compounds, process for preparing the same, and pharmaceutical compositions containing the same background of the invention
WO2002030353A2 (en) 2000-10-12 2002-04-18 Smithkline Beecham Corporation NF-λB INHIBITORS

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107739370A (zh) * 2017-10-26 2018-02-27 中国药科大学 吡咯酮类brd4蛋白抑制剂的制备方法以及用途
CN107739370B (zh) * 2017-10-26 2021-03-30 中国药科大学 吡咯酮类brd4蛋白抑制剂的制备方法以及用途

Also Published As

Publication number Publication date
CA2454702A1 (en) 2003-02-06
BR0211472A (pt) 2004-11-09
DE60218048T2 (de) 2007-08-09
US20040235821A1 (en) 2004-11-25
EP1421079B1 (en) 2007-02-07
ATE353327T1 (de) 2007-02-15
JP2004536869A (ja) 2004-12-09
NO20040314L (no) 2004-03-25
JP2010111683A (ja) 2010-05-20
DE60218048D1 (de) 2007-03-22
US7098240B2 (en) 2006-08-29
NZ530751A (en) 2005-09-30
MXPA04000755A (es) 2004-04-20
EP1421079A1 (en) 2004-05-26
SE0102617D0 (sv) 2001-07-25
ZA200400494B (en) 2005-04-22
ES2280559T3 (es) 2007-09-16
IL160023A0 (en) 2004-06-20
KR20040018521A (ko) 2004-03-03
WO2003010163A1 (en) 2003-02-06

Similar Documents

Publication Publication Date Title
CN1538968A (zh) 新型化合物
CN1149209C (zh) 与多巴胺d3受体具有亲和力的三唑化合物
CN1164574C (zh) 苯氧基丙胺类化合物
CN1110493C (zh) 氨基噻吩羧基酰胺及其作为磷酸二酯酶抑制剂的用途
CN1249051C (zh) 毒蕈碱性激动剂
CN1541214A (zh) 新化合物
CN1169789C (zh) 用于治疗中枢神经系统疾病的氨基烷氧基咔唑
CN1425012A (zh) 杂芳族甲酰胺衍生物及其作为酶ikk－2的抑制剂的用途
CN1678306A (zh) 在炎性、变应性和增生性疾病中用作糖皮质激素模拟物的3－(磺酰氨基乙基)－吲哚衍生物
CN1264382A (zh) 新的化合物
CN1649581A (zh) 取代的3－氨基－噻吩并[2,3－b]吡啶－2－羧酸酰胺化合物及其制备方法和用途
CN1486309A (zh) 作为多巴胺D<sub>3</sub>受体调节剂(精神抑制药)的四氢苯并氮杂䓬衍生物
HK1045518A1 (zh) 用作抗病毒剂的4-氧代-4，7-二氢-噻吩并[2，3-b]吡啶-5-甲酰胺类化合物
CN1871236A (zh) 用于治疗5－HT6受体相关病症的新的四氢螺{哌啶－2,7′－吡咯并[3,2－b]吡啶}衍生物和新的吲哚衍生物
CN1738812A (zh) 作为酶ikk－2抑制剂的噻吩甲酰胺
CN1561338A (zh) 作为5－羟基色胺－6配体的苯并二氢吡喃衍生物
CN1771244A (zh) 作为5－羟色胺－6配体的杂环－3－磺酰基吲唑
CN1025500C (zh) 杂芳基3-氧-丙腈衍生物的制备方法
CN1910157A (zh) 对受体cbi有亲和性的n′－(1,5－二苯基－1h－吡唑－3－基)磺酰胺衍生物
CN1774433A (zh) 作为胰高血糖素受体拮抗剂的取代的3－氰基噻吩乙酰胺
CN1309654A (zh) 联苯基衍生物
CN1022322C (zh) 稠合吡唑3-氧代-丙腈衍生物的制备方法
CN1832740A (zh) 吲哚－5磺酰胺衍生物及其制备和其作为5－ht－6调节剂的用途
CN1826346A (zh) 作为5－羟色胺－6配位体的n－磺酰基杂环吡咯基烷基胺化合物
CN1245400C (zh) N－取代苯并噻唑磺胺衍生物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication